Compare Bank Maspion Indonesia Tbk. (BMAS) vs Cipta Sarana Medika Tbk. (DKHH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bank Maspion Indonesia Tbk. vs Cipta Sarana Medika Tbk. — how do they compare? Bank Maspion Indonesia Tbk. trades at Rp490 (market cap 8.96T, 76.1K 24h volume), while Cipta Sarana Medika Tbk. trades at Rp64 (market cap 160.67B, 14.05M 24h volume). The key difference: Bank Maspion Indonesia Tbk. is far larger — about 55.8× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (14.05M versus 76.1K). Which is the better fit depends on your goals.
| BMAS | DKHH | |
|---|---|---|
Market Cap | 8.96T | 160.67B |
Volume | 76.1K | 14.05M |
Lot | 761 | 140.49K |
Turnover | 37.5M | 899.67M |
Average Price | 492.76 | 64.04 |
Value | 37.5M | 899.67M |
Indicative Equilibrium Price | 490 | 64 |
Indicative Equilibrium Volume | 99 | 100 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bank Maspion Indonesia Tbk.
PT Bank Maspion Indonesia Tbk (the Bank) was established on November 6, 1989 based on Notarial Deed No. 68 of Soetjipto, S.H., which was amended by Notarial Deed No. 49 dated December 5, 1989 of the same notary. The Bank started its commercial operations in 1990. As of December 31, 2012, the Bank has 10 domestic branches, 27 sub-branches, 10 cash offices and 45 Automatic Teller Machines (ATMs) located at Surabaya, Jakarta, Semarang, Denpasar, Medan, Bandung, Makassar, Malang, Solo and Purwokerto.
Read more on BMAS →About Cipta Sarana Medika Tbk.
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →
